Biotech Stock News (BIIB) (LLY) (AVXL) (ITEK) (XOMA)

Biogen (NASDAQ:BIIB) On July 22, 2015 shares of Biogen fell about 4% after reporting mixed results for its Alzheimer’s drug known as aducanumab. This phase 1b trial was known as the “PRIME” trial and patients were randomized into two different dosing groups. One group of patients either took 1 mg, 3 mg , 6 mg … Read more